Advertisement

Topics

Latest "Boston Biostatistics Incorporated" News Stories

21:07 EST 9th December 2018 | BioPortfolio

Here are the most relevant search results for "Boston Biostatistics Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Boston Biostatistics Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Boston Biostatistics Incorporated for you to read. Along with our medical data and news we also list Boston Biostatistics Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Boston Biostatistics Incorporated Companies for you to search.

Showing "Boston Biostatistics Incorporated" News Articles 1–25 of 2,100+

Relevant

#jobs #lifescience Longwood Medical Area: Research Associate – Biostatistics and Computational Biology

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Longwood Medical Area: Research Associate – Biostatistics and Computational Biology . Depends on Experience: Longwood Medical Area: Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings … Continue reading → Cet article #jobs #...


Former Akebia and Merrimack Employees Convicted of Insider Trading

Schultz Chan, the former director of biostatistics at Cambridge-based Akebia Therapeutics and Songjiang Wang, a director of statistical programming at Merrimack Pharmaceuticals (MACK) were convicted of insider trading by a federal grand jury in Boston.

HIPAA Settlements: Three Boston Hospitals Pay $1M in Fines for “Boston Med” Filming

Heather Landi, Associate EditorThree Boston hospitals that allowed film crews to film “Boston Med” on premises have settled with the U.S. Department of Health and Human Services, Office for Civil Rights (OCR) over potential violations of the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule.


Boston Medical Center, Boston University receive $1.58M CDC grant in efforts to reduce fetal alcohol spectrum disorders

(Boston Medical Center) A new collaborative program led by Boston Medical Center (BMC) and funded by the Centers for Disease Control and Prevention (CDC), will train healthcare providers on how to best screen and counsel patients regarding unsafe alcohol use including the risks of alcohol use during pregnancy.

Massachusetts healthcare turmoil: I’m quoted in the Boston Globe and Boston Herald

I’m always happy to speak with the press to provide my take on healthcare business and policy. In the last few days I’ve been quoted in a few outlets: Today’s Boston Globe: In a sudden departure, Harvard Pilgrim CEO resigns amid questions about his behavior Harvard Pilgrim and Partners each said Tuesday that Schultz’s resignation Read More The post Massachusetts healthcare turm...

Boston Globe and Boston Herald quote David Williams on Harvard Pilgrim CEO departure

Boston Globe: In a sudden departure, Harvard Pilgrim CEO resigns amid questions about his behavior Harvard Pilgrim and Partners each said Tuesday that Schultz’s resignation does not affect their discussions about a possible merger. But David E. Williams, a Boston health care consultant, predicted the leadership change at Harvard Pilgrim would slow any other major Read More

Boston Scientifiс представляет систему визуализации ...

ЭДИНБУРГ (EDINBURGH), Шотландия, 26 сентября 2018 г. /PRNewswire/ -- Компания Boston Scientific Corporation (код NYSE: BSX) сегодня сообщила о выпуске системы визуализации процесса глубокой стимуляции Read more...

MSL BOSTON Executives Elevated To National Leadership Team

BOSTON, Sept. 6, 2018 /PRNewswire/ -- Today, MSL announced four executives from MSL Boston were elevated to national leadership roles on the newly formed MSL Read more...

Boston Scientific Continues M&A Spree with $160 Million Deal for Veniti, Lays Off 85 in Massachus...

Two days after Boston Scientific laid off 85 employees at a Burlington, Mass. manufacturing site, the company forked over up to $160 million to acquire California stent maker Veniti, Inc. The deal marks the third acquisition for Boston Scientific in two months.

Humana to open digital health centre in Boston

US health firm Humana is to expand its capability in technology, digital health and analytics with a new centre in Boston, Massachusetts. Humana will establish the new operation in Boston’s Seaport neighbourhood, according to the website news-medi...

Boston Children's Hospital accelerates genomic sequencing to expand existing genomic database

(Boston Children's Hospital) Boston Children's Hospital has embarked on a strategic initiative to expand its research genomics gateway, with plans to sequence the DNA of 3,000 patients with epilepsy or inflammatory bowel disease and their family members.

HIPAA Settlements: Three Boston Hospitals Pay $1M in Fines for “Boston Trauma” Filming

Heather Landi, Associate EditorThree Boston hospitals that allowed film crews to film an ABC documentary on their premises have settled with the U.S. Department of Health and Human Services, Office for Civil Rights (OCR) over potential violations of the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule.

Innovate, Amarex Sign Agreement

To provide data management and biostatistics for its planned Phase 3 celiac disease trial

Xconomy Awards 2018 Gala Honors the Best of Boston Life Science: Slideshow

The 2nd annual Xconomy Awards Gala was a who’s who of Boston biotech. About 400 people from across the life science ecosystem came out to Boston’s Hynes Convention Center last month to celebrate the finalists over dinner and drinks, find out who got to take home the awards, and reconnect with friends and colleagues. It […]

Innovate Biopharmaceuticals Enters into an Agreement with Amarex Clinical Research for Data Management and Biostatistics for Phase 3 Celiac Disease Trial

RALEIGH, N.C., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, today announced it signed an agreement with Amarex Clinical Research to provide data management and biostatistics for its planned Phase 3 celiac disease trial. Pursuant to the ...

Beam, Celsius & Arrakis at Boston’s Life Science Disruptors Oct. 17

For the sixth year in a row, Xconomy will hold our fall Boston life sciences event, “Boston’s Life Science Disruptors”, on Wednesday October 17 at MIT’s Koch Institute in Kendall Square. Join us for this unique event featuring candid stories from some of New England’s most radical biotech company leaders, founders, and VC backers who […]

Boston Gay Men's Chorus and Gay Men's Chorus of Los Angeles Face Off in World Series Challenge

BOSTON, Oct. 23, 2018 /PRNewswire/ -- Today, the Boston Gay Men's Chorus (BGMC) issued a World Series challenge to the Gay Men's Chorus of Los Read more...

Boston Scientific Prevails in German Edwards Lifesciences Litigation

Court Rules Edwards Lifesciences' Next-Generation Valve Infringes Boston Scientific Patent and Grants Right to Enjoin Sales in Germany MARLBOROUGH, Mass., Oct. 23, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the District Court of Dusseldorf, Germany has determined that Edwards Lifesciences Corporation's Sapien 3 Ultra™ device infringed a patent – establish...

We Were Invited To Speak At Biotech Week Boston, Here’s How it Went

As one of the main media sponsors of some of the EBD Group events, we have a great relationship, and this year we were also invited to Boston to speak at BioPharm America! 🇺🇸🗽  Philip was excited to attend this year as he was ... The post We Were Invited To Speak At Biotech Week Boston, Here’s How it Went appeared first on Labiotech.eu.

Boston Scientific Continues M&A Streak with $202M Deal for Cryterion

Boston Scientific is adding on to its heart rhythm management business again, this time with a deal to acquire atrial fibrillation device startup Cryterion Medical for $202 million. The cash payment covers the 65 percent of Cryterion that the Marlborough, MA, medical device giant does not already own. Boston Scientific (NYSE: BSX) had been an […]

Boston Scientific enters $4.2B deal to buy BTG

Boston Scientific has reached an agreement to acquire UK-based BTG for $4.2 billion in cash, which represents a 36.6% premium -More- 

Novartis, GSK ink deals with Boston biotech

The two deals more than double the size of Boston Pharmaceuticals' drug pipeline to 15 candidates.

Boston College launches Global Observatory on Pollution and Health

(Boston College) Boston College has established the Global Observatory on Pollution and Health to analyze pollution control initiatives and find solutions to prevent pollution-related diseases that claim an estimated 9 million lives around the world each year.

Boston Scientific announces $202M buyout of Cryterion Medical

Boston Scientific has agreed to pay around $202 million in cash upfront for the remaining 65% stake it does not already own i -More- 

Boston Scientific to pay up to $600M for Augmenix

Boston Scientific has entered an agreement to pay $500 million in cash upfront plus sales-based milestones worth up to $100 m -More- 


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks